dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada inhibitors GLP-1RAs: cardiovascular safety and benefits Complete pharmacology and pharmacotherapy of
Description
Difference in postprandial GLP-1 response despite similar glucose kinetics after consumption of wheat breads with different particle size in healthy men
GLP1s in higher amounts also act on portions of the brain that suppress appetite and signal satiety (feeling full)
Fidler MC, Sanchez M, Raether B, et al
Glucose-dependent insulinotropic polypeptide suppresses peripheral arterial remodeling in male mice
These drugs offer different options for healthcare providers to tailor treatments to individual patient needs, considering factors such as comorbidities, age, and treatment preferences
